BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36845147)

  • 1.
    Shareef ZA; Hachim MY; Talaat IM; Bhamidimarri PM; Ershaid MNA; Ilce BY; Venkatachalam T; Eltayeb A; Hamoudi R; Hachim IY
    Front Immunol; 2023; 14():978236. PubMed ID: 36845147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of Dickkopf-3 (Dkk3), TGFB1 and ECM-1 in prostate cancer.
    Al Shareef Z; Hachim MY; Bouzid A; Talaat IM; Al-Rawi N; Hamoudi R; Hachim IY
    Front Mol Biosci; 2024; 11():1351888. PubMed ID: 38855324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-363-3p promotes prostate cancer tumor progression by targeting Dickkopf 3.
    Xu LZ; Ning JZ; Ruan Y; Cheng F
    J Clin Lab Anal; 2022 Apr; 36(4):e24360. PubMed ID: 35303365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer.
    Zenzmaier C; Sampson N; Plas E; Berger P
    Prostate; 2013 Sep; 73(13):1441-52. PubMed ID: 23765731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway.
    Xi M; Cheng L; Hua W; Zhou YL; Gao QL; Yang JX; Qi SY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1002-1011. PubMed ID: 30779066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue.
    Zenzmaier C; Untergasser G; Hermann M; Dirnhofer S; Sampson N; Berger P
    Prostate; 2008 Apr; 68(5):540-7. PubMed ID: 18247400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
    Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
    Yu WJ; Wang YW; Xie ZG; You JF; Wang JL; Cui XL; Pei F; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):88-94. PubMed ID: 20388373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)-3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A.
    Bhattacharyya S; Feferman L; Tobacman JK
    Prostate; 2019 May; 79(7):689-700. PubMed ID: 30801800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1.
    Al Shareef Z; Kardooni H; Murillo-Garzón V; Domenici G; Stylianakis E; Steel JH; Rabano M; Gorroño-Etxebarria I; Zabalza I; Vivanco MD; Waxman J; Kypta RM
    Oncogene; 2018 Sep; 37(39):5305-5324. PubMed ID: 29858602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.
    Dozmorov MG; Azzarello JT; Wren JD; Fung KM; Yang Q; Davis JS; Hurst RE; Culkin DJ; Penning TM; Lin HK
    BMC Cancer; 2010 Dec; 10():672. PubMed ID: 21134280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bax-interacting factor-1 inhibits cell proliferation and promotes apoptosis in prostate cancer cells.
    Xu L; Wang Z; He SY; Zhang SF; Luo HJ; Zhou K; Li XF; Qiu SP; Cao KY
    Oncol Rep; 2016 Dec; 36(6):3513-3521. PubMed ID: 27748942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lnc‑MICAL2‑1 sponges miR‑25 to regulate DKK3 expression and inhibits activation of the Wnt/β‑catenin signaling pathway in breast cancer.
    Yao J; Li G; Liu M; Yang S; Su H; Ye C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34970696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells.
    Sheng X; Li WB; Wang DL; Chen KH; Cao JJ; Luo Z; He J; Li MC; Liu WJ; Yu C
    Mol Med Rep; 2015 Oct; 12(4):4867-76. PubMed ID: 26126522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Suppressor Role and Clinical Significance of the
    Liang YX; Liang YK; Zou ZH; Zhuo YJ; Ye JH; Zhu XJ; Cai ZD; Lin ZY; Mo RJ; Wu SL; Zhang YQ; Zhong WD
    Dis Markers; 2022; 2022():8724035. PubMed ID: 35548776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis.
    Cheng JY; Brown TC; Murtha TD; Stenman A; Juhlin CC; Larsson C; Healy JM; Prasad ML; Knoefel WT; Krieg A; Scholl UI; Korah R; Carling T
    BMC Cancer; 2017 Mar; 17(1):164. PubMed ID: 28249601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Proteomic and Phosphoproteomics Analysis of DKK3 Signaling Reveals Activated Kinase in the Most Aggressive Gallbladder Cancer.
    Gondkar K; Sathe G; Joshi N; Nair B; Pandey A; Kumar P
    Cells; 2021 Feb; 10(3):. PubMed ID: 33670899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dickkopf-related protein 3 promotes cell adhesion and invasion during progression of lung adenocarcinoma.
    Komori Y; Kano J; Nakano N; Sakashita S; Sakamoto N; Noguchi M
    Pathol Int; 2019 Nov; 69(11):646-654. PubMed ID: 31682048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach.
    Han MH; Min KW; Noh YK; Kim JM; Cheong JH; Ryu JI; Won YD; Koh SH; Myung JK; Park JY; Kwon MJ
    Cancer Immunol Immunother; 2022 Dec; 71(12):3013-3027. PubMed ID: 35599254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.